Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Philippe Gautret; Jean-Christophe Lagier; Stéphane Honoré; van Thuan Hoang; Philippe Colson; Didier Raoult

doi:10.1016/j.ijantimicag.2020.106243

Journal articles

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Philippe Gautret ¹ Jean-Christophe Lagier ² Stéphane Honoré ³ van Thuan Hoang ¹ Philippe Colson ² Didier Raoult ²

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes

2 MEPHI - Microbes évolution phylogénie et infections

3 Service Pharmacie [Hôpital de la Timone - APHM]

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Microbiology and Parasitology / Bacteriology

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Life Sciences [q-bio] / Microbiology and Parasitology / Parasitology

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Life Sciences [q-bio] / Human health and pathology / Emerging diseases

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03215698
Contributor : Isabelle Combe <>
Submitted on : Monday, May 3, 2021 - 2:56:54 PM
Last modification on : Tuesday, May 4, 2021 - 3:23:52 AM

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Links full text

Identifiers

Collections

Citation

Export

Metrics

6

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

6